Cargando…

Effect of Bortezomib on the Efficacy of AAV9.SERCA2a Treatment to Preserve Cardiac Function in a Rat Pressure-Overload Model of Heart Failure

Adeno-associated virus (AAV)-based vectors are promising vehicles for therapeutic gene delivery, including for the treatment of heart failure. It has been demonstrated for each of the AAV serotypes 1 through 8 that inhibition of the proteasome results in increased transduction efficiencies. For AAV9...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaanine, Antoine H., Nonnenmacher, Mathieu, Kohlbrenner, Erik, Jin, Dongzhu, Kovacic, Jason C., Akar, Fadi G., Hajjar, Roger J., Weber, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976435/ https://www.ncbi.nlm.nih.gov/pubmed/24572786 http://dx.doi.org/10.1038/gt.2014.7

Ejemplares similares

High-dose chloroquine is metabolically cardiotoxic by inducing lysosomes and mitochondria dysfunction in a rat model of pressure overload hypertrophy
por: Chaanine, Antoine H, et al.
Publicado: (2015)

Safety and long-term efficacy of AAV1.SERCA2a using nebulizer delivery in a pig model of pulmonary hypertension
por: Watanabe, Shin, et al.
Publicado: (2018)

SUMO1-dependent modulation of SERCA2a in heart failure
por: Kho, Changwon, et al.
Publicado: (2011)

Mitochondrial Integrity and Function in the Progression of Early Pressure Overload–Induced Left Ventricular Remodeling
por: Chaanine, Antoine H., et al.
Publicado: (2017)

Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling
por: Karakikes, Ioannis, et al.
Publicado: (2013)

Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors
por: Zeltner, Nadja, et al.
Publicado: (2010)

Primary Effect of SERCA2a Gene Transfer on Conduction Reserve in Chronic Myocardial Infarction
por: Motloch, Lukas J., et al.
Publicado: (2018)

Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device – the SERCA-LVAD TRIAL
por: Lyon, A. R., et al.
Publicado: (2020)

SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice
por: Shin, Jin-Hong, et al.
Publicado: (2011)

Every little bit helps: A single-residue switch in a vascular AAV enables blood-brain barrier penetration
por: Grimm, Dirk, et al.
Publicado: (2023)

Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice
por: Liu, Lifei, et al.
Publicado: (2018)

Identification and Characterization of p300-Mediated Lysine Residues in Cardiac SERCA2a
por: Gorski, Przemek A., et al.
Publicado: (2023)

Elevated whole muscle phosphatidylcholine: phosphatidylethanolamine ratio coincides with reduced SERCA activity in murine overloaded plantaris muscles
por: Fajardo, Val A., et al.
Publicado: (2018)

Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure
por: Kho, Changwon, et al.
Publicado: (2015)

Gene Remodeling in Type 2 Diabetic Cardiomyopathy and Its Phenotypic Rescue with SERCA2a
por: Karakikes, Ioannis, et al.
Publicado: (2009)

Enhancing atrial‐specific gene expression using a calsequestrin cis‐regulatory module 4 with a sarcolipin promoter
por: Yoo, Jimeen, et al.
Publicado: (2018)

Contractile Behavior of Mouse Aorta Depends on SERCA2 Isoform Distribution: Effects of Replacing SERCA2a by SERCA2b
por: Fransen, Paul, et al.
Publicado: (2020)

Effectiveness of gene delivery systems for pluripotent and differentiated cells
por: Rapti, Kleopatra, et al.
Publicado: (2015)

Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
por: Nordén, Einar Sjaastad, et al.
Publicado: (2021)

SENP2-mediated SERCA2a deSUMOylation increases calcium overload in cardiomyocytes to aggravate myocardial ischemia/reperfusion injury
por: Luo, Yuanyuan, et al.
Publicado: (2023)

Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension
por: Bisserier, Malik, et al.
Publicado: (2021)

SERCA2a gene transfer prevents intimal proliferation in an organ culture of human internal mammary artery
por: Lipskaia, Larissa, et al.
Publicado: (2012)

Sirtuin 5 levels are limiting in preserving cardiac function and suppressing fibrosis in response to pressure overload
por: Guo, Angela H., et al.
Publicado: (2022)

A Decoy Peptide Targeted to Protein Phosphatase 1 Attenuates Degradation of SERCA2a in Vascular Smooth Muscle Cells
por: Jang, Seung Pil, et al.
Publicado: (2016)

Altered SERCA Expression in Breast Cancer
por: Christodoulou, Panayiota, et al.
Publicado: (2021)

Morphological Stages of Mitochondrial Vacuolar Degeneration in Phenylephrine-Stressed Cardiac Myocytes and in Animal Models and Human Heart Failure
por: Chaanine, Antoine H.
Publicado: (2019)

Metabolic Remodeling and Implicated Calcium and Signal Transduction Pathways in the Pathogenesis of Heart Failure
por: Chaanine, Antoine H.
Publicado: (2021)

Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca(2+) and phosphorylation
por: Weber, Daniel K, et al.
Publicado: (2021)

Differential Modulation of SERCA2 Isoforms by Calreticulin
por: John, Linu M., et al.
Publicado: (1998)

SERCA is critical to control the Bowditch effect in the heart
por: Balcazar, Darío, et al.
Publicado: (2018)

Targeting oncogenic Notch signaling with SERCA inhibitors
por: Pagliaro, Luca, et al.
Publicado: (2021)

Truncations of the titin Z-disc predispose to a heart failure with preserved ejection phenotype in the context of pressure overload
por: Ye, Lei, et al.
Publicado: (2018)

Leukocytic Toll-Like Receptor 2 Deficiency Preserves Cardiac Function And Reduces Fibrosis In Sustained Pressure Overload
por: Wang, Jiong-Wei, et al.
Publicado: (2017)

Vagal nerve stimulation preserves right ventricular function in a rat model of right ventricular pressure overload
por: Yoshida, Keimei, et al.
Publicado: (2022)

SERCA2a tyrosine nitration coincides with impairments in maximal SERCA activity in left ventricles from tafazzin‐deficient mice
por: Braun, Jessica L., et al.
Publicado: (2019)

Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions
por: Weber, Thomas
Publicado: (2021)

LncRNA ZFAS1 as a SERCA2a Inhibitor to Cause Intracellular Ca(2+) Overload and Contractile Dysfunction in a Mouse Model of Myocardial Infarction
por: Zhang, Ying, et al.
Publicado: (2018)

SYST-13 AAV VECTOR ENCODING FC MODIFIED HER2 ANTIBODIES REDUCES TUMOR BURDEN WITH MINIMIZED PERIPHERAL EXPOSURE IN MODELS OF BREAST CANCER BRAIN METASTASIS
por: Laks, Dan, et al.
Publicado: (2023)

Bortezomib
por: Rajappa, Senthil
Publicado: (2010)

Lercanidipine Synergistically Enhances Bortezomib Cytotoxicity in Cancer Cells via Enhanced Endoplasmic Reticulum Stress and Mitochondrial Ca(2+) Overload
por: Lee, A Reum, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mur9if1ke3ds9t8s5ud04kfdmf